成人慢性气道炎症性疾病急症诊疗急诊专家共识
-
-
-
[1] 中华医学会呼吸病学分会哮喘学组.上-下气道慢性炎症性疾病联合诊疗与管理专家共识[J].中华医学杂志,2017,97(26):2001-2022.
[2] 慢性气道炎症性疾病气道黏液高分泌管理中国专家共识编写组.慢性气道炎症性疾病气道黏液高分泌管理中国专家共识[J].中华结核和呼吸杂志,2015,38(10):723-729.
[3] Huang K,Yang T,Xu J,et al.Prevalence,Risk Factors,and Management of Asthma in China:A National Cross-Sectional Study[J].Lancet,2019,394(10196):407-418.
[4] Wang C,Xu J,Yang L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH]study):a national cross-sectional study[J].Lancet,2018,391(10131):1706-1717.
[5] GINA Executive and Science Committee.Global Strategy for asthma management and prevention updated 2020[EB/OL].http://www.gina.com.
[6] GINA Executive and Science Committee.Global Strategy for asthma management and prevention updated 2019[EB/OL].http://www.gina.com.
[7] Global Initiative for Chronic Obstructive Lung Disease(GOLD):Global Strategy for the Diagnosis,Management and Prevention of Chronic Obstructive Pulmonary Disease(2021 Report)[EB/OL].https://goldcopd.org/2021-gold-reports/
[8] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J].国际呼吸杂志,2017,37(14):1041-1057.
[9] 林江涛,王文巧,周新,等.我国中心城市支气管哮喘患者急性发作征兆及其自我管理水平的调查分析[J].中华医学杂志,2017,97(30):2329-2332.
[10] 中华医学会呼吸病学分会哮喘学组,中国哮喘联盟.支气管哮喘急性发作评估及处理中国专家共识[J].中华内科杂志,2018,57(1):4-14.
[11] 急诊氧气治疗专家共识组.急诊氧气治疗专家共识[J].中华急诊医学杂志,2018,27(4):355-360.
[12] 王亚,孙峰,付阳阳.成人院内心肺复苏质量控制临床实践专家共识[J].中国急救医学,2018,38(8):649-653.
[13] Higgs A,McGrath BA,Goddard C,et al.Guidelines for the management of tracheal intubation in critically ill adults[J].Br J Anaesth,2018,120(2):323-352.
[14] Trouillet JL,Collange O,Belafia F,et al.Tracheotomy in the intensive care unit:guidelines from a French expert panel[J].Ann Intensive Care,2018,8(1):37.
[15] O'Driscoll BR,Howard LS,Davison AG,et al.BTS guideline for emergency oxygen use in adult patients[J].Thorax,2008,63 Suppl 6:vi1-68.
[16] 中华医学会呼吸病学分会呼吸危重症医学学组,中国医师协会呼吸医师分会危重症医学工作委员会.成人经鼻高流量湿化氧疗临床规范应用专家共识[J].中华结核和呼吸杂志,2019,42(2):83-91.
[17] Kirkland SW,Vandenberghe C,Voaklander B,et al.Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma[J].Cochrane Database Syst Rev,2017,1:CD001284.
[18] Zhang J,Zheng J,Huang K,et al.Use of glucocorticoids in patients with COPD exacerbations in China:a retrospective observational study[J].Ther Adv Respir Dis,2018,12:1753466618769514.
[19] Zheng JP,Zhang J,Ma LJ,et al.Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease:A Post-Hoc Analysis[J].Int J Chron Obstruct Pulmon Dis,2019,14:2725-2731.
[20] Beasley R,Holliday M,Reddel HK,et al.Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma[J].N Engl J Med,2019,380(21):2020-2030.
[21] O'Byrne PM,FitzGerald JM,Bateman ED,et al.Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma[J].N Engl J Med,2018,378(20):1865-1876.
[22] Ferguson GT,Rabe KF,Martinez FJ,et al.Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease(KRONOS):a double-blind,parallel-group,multicentre,phase 3 randomised controlled trial[J].Lancet Respir Med,2018,6(10):747-758.
[23] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2020年版)[J].中华结核和呼吸杂志,2020,43(12):1023-1048.
[24] 李晓桐,翟所迪,王强,等.《严重过敏反应急救指南》推荐意见[J].药物不良反应杂志,2019,21(2):85-91.
[25] Ornico SR,Lobo SM,Sanches HS,et al.Noninvasive ventilation immediately after extubation improves weaning outcome after acute respiratory failure:a randomized controlled trial[J].Crit Care,2013,17(2):R39.
[26] Vargas F,Clavel M,Sanchez-Verlan P,et al.Intermittent noninvasive ventilation after extubation in patients with chronic respiratory disorders:a multicenter randomized controlled trial(VHYPER)[J].Intensive Care Med,2017,43(11):1626-1636.
[27] Global Initiative for Chronic Obstructive Lung Disease(GOLD):Global Strategy for the Diagnosis,Management and prevention of Chronic Obstructive Pulmonary Disease.(revised 2013)[EB/OL].http://www.goldcopd.org.
[28] Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections--summary[J].Clin Microbiol Infect,2011,17 Suppl 6:1-24.
[29] Kuyper LM,Paré PD,Hogg JC,et al.Characterization of airway plugging in fatal asthma[J].Am J Med,2003,115(1):6-11.
[30] Aikawa T,Shimura S,Sasaki H,et al.Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack[J].Chest,1992,101(4):916-921.
[31] Hogg JC,Chu FS,Tan WC,et al.Survival after lung volume reduction in chronic obstructive pulmonary disease:insights from small airway pathology[J].Am J Respir Crit Care Med,2007,176(5):454-459.
[32] 王雯,黄克武,刘秋云,等.支气管哮喘规范化管理与教育对哮喘控制的效果评析[J].中华哮喘杂志(电子版),2011,05(6):415-419.
[33] 中华医学会呼吸病学分会哮喘学组.支气管哮喘患者自我管理中国专家共识[J].中华结核和呼吸杂志,2018,41(3):171-178.
[34] Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease 2020 report[EB/OL].https://goldcopd.org/gold-reports/
[35] Spruit MA,Singh SJ,Garvey C,et al.An official American Thoracic Society/European Respiratory Society statement:key concepts and advances in pulmonary rehabilitation[J].Am J Respir Crit Care Med,2013,188(8):e13-64.
[36] Reid WD,Yamabayashi C,Goodridge D,et al.Exercise prescription for hospitalized people with chronic obstructive pulmonary disease and comorbidities:a synthesis of systematic reviews[J].Int J Chron Obstruct Pulmon Dis,2012,7:297-320.
[37] Philip G,Nayak AS,Berger WE,et al.The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis[J].Curr Med Res Opin,2004,20(10):1549-1558.
[38] Holguin F,Cardet JC,Chung KF,et al.Management of severe asthma:a European Respiratory Society/American Thoracic Society guideline[J].Eur Respir J,2020,55(1):1900588.
[39] Albert RK,Connett J,Bailey WC,et al.Azithromycin for prevention of exacerbations of COPD[J].N Eng J Med,2011,365(8):689-698.
[40] Rennard SI,Schachter N,Strek M,et al.Cilomilast for COPD:results of a 6-month,placebo-controlled study of a potent,selective inhibitor of phosphodiesterase 4[J].Chest,2006,129(1):56-66.
[41] Lipson DA,Barnhart F,Brealey N,et al.Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD[J].N Engl J Med,2018,378(18):1671-1680.
[42] Papi A,Vestbo J,Fabbri L,et al.Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease(TRIBUTE):a double-blind,parallel group,randomised controlled trial[J].Lancet,2018,391(10125):1076-1084.
[43] Hui Y,Li L,Qian J,et al.Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma[J].Exp Ther Med,2014,7(3):630-634.
[44] Wang H,Lin X,Hao C,et al.A double-blind,placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients[J].Allergy,2006,61(2):191-197.
-
计量
- 文章访问数: 134
- PDF下载数: 637
- 施引文献: 0
下载: